TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors.

Alexander N Starodub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.